Breast Cancer and the Pill

Russo I.H. Cigarette smoking and risk of breast cancer in women. Lancet 2002; 360: 1033–4

Black W.C. , Nease R.F. , Tosteson A.N. Perceptions of breast cancer risk and screening effectiveness in women younger than 50 years of age. J Natl Cancer Inst USA 1995; 87: 720–31

Bartlett C. , Sterne J. , Egger M. What is newsworthy? Longitudinal study of the reporting of medical research in two British newspapers. BMJ 2002; 325: 81–4

Blanchard D. , Erblich J. , Montgomery G.H. Read all about it: the over-representation of breast cancer in popular magazines. Prev Med 2002; 35: 343–8

McPherson K. , Steel C.M. , Dixon J.M. Breast cancer: epidemiology, risk factors and genetics. BMJ 2000; 321: 624–8

Band P.R. , Le H.D. , Fang R. Carcinogenic and endocrine disruptive effects of cigarette smoke and risk of breast cancer. Lancet 2002; 360: 1044–9

Li C.I. , Daling J.R. , Malone K.E. Incidence of invasive breast cancer by hormone receptor status from 1992 to 1998. J Clin Oncol 2003; 21: 28–34

Going J.J. , Anderson T.J. , Battersby S. Proliferative and secretory activity in human breast during natural and artificial menstrual cycles. Am J Pathol 1982; 130: 193–203

Miller W.R. Hormonal factors and risk of breast cancer. Lancet 1993; 341: 25–6

Kalache A. , Maguire A. , Thompson S.G. Age at last full-term pregnancy and risk of breast cancer. Lancet 1993; 341: 33–5

Collaborative Group on Hormonal Factors in Breast Cancer. Breast cancer and breastfeeding: collaborative reanalysis of individual data from 47 epidemiological studies in 30 countries, including 50 302 women with breast cancer and 96 973 women without the disease. Lancet 2002; 360: 187–95

Sperof L. , Darney P. Contraception in the USA. In: A Clinical Guide for Contraception 2nd edn. Baltimore: Williams & Wilkins, 1996: 7

Collaborative Group on Hormonal Factors in Breast Cancer. Breast cancer and hormonal contraceptives: collaborative reanalysis of individual data on 53 297 women with breast cancer and 100 239 women without breast cancer from 54 epidemiological studies. Lancet 1996; 347: 1713–27

Marchbanks P.A. , McDonald J.A. , Wilson H.G. Oral contraceptives and the risk of breast cancer. N Engl J Med 2002; 346: 2025–32

Terry M.B. , Gammon M.D. , Schoenberg J.B. Oral contraceptive use and Cyclin D1 overexpression in breast cancer among young women. Cancer Epidemiol Biomarkers Prev 2002; 11: 1100–3

Skegg D.C.G. , Noonan E.A. , Paul C. Depot medroxyprogesterone acetate and breast cancer. JAMA 1995; 273: 799–804

WHO/RHR. Improving Access to Quality Care in Family Planning. Medical Eligibility Criteria for Contraceptive Use. Geneva: WHO, 2000